ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

In Brief: Illinois Comprehensive Center Core Grant Approved, Probably Will Be Funded in FY 79

September 29, 1978

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999